Hsu CY - Search Results

1

CKD-EPI eGFR categories were better than MDRD categories for predicting mortality in a range of populations.

Hsu CY. Hsu CY. Ann Intern Med. 2012 Nov 20;157(10):JC5-12. doi: 10.7326/0003-4819-157-10-201211200-02012. Ann Intern Med. 2012. PMID: 23165688 No abstract available.

2

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency.

Hsu CY, Vittinghoff E, Lin F, Shlipak MG. Hsu CY, et al. Ann Intern Med. 2004 Jul 20;141(2):95-101. doi: 10.7326/0003-4819-141-2-200407200-00007. Ann Intern Med. 2004. PMID: 15262664

3

Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study.

Shah SJ, Hsu CY. Shah SJ, et al. Among authors: hsu cy. Am J Med. 2004 Dec 15;117(12):948-52. doi: 10.1016/j.amjmed.2004.09.004. Am J Med. 2004. PMID: 15629734 No abstract available.

4

Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.

Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Hsu CY, et al. Arch Intern Med. 2005 Apr 25;165(8):923-8. doi: 10.1001/archinte.165.8.923. Arch Intern Med. 2005. PMID: 15851645

5

Body mass index and risk for end-stage renal disease.

Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Hsu CY, et al. Ann Intern Med. 2006 Jan 3;144(1):21-8. doi: 10.7326/0003-4819-144-1-200601030-00006. Ann Intern Med. 2006. PMID: 16389251

6

Risk factors for end-stage renal disease: 25-year follow-up.

Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Hsu CY, et al. Arch Intern Med. 2009 Feb 23;169(4):342-50. doi: 10.1001/archinternmed.2008.605. Arch Intern Med. 2009. PMID: 19237717 Free PMC article.

7

ACP Journal Club. Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD.

Hsu CY. Hsu CY. Ann Intern Med. 2010 Nov 16;153(10):JC5-3. doi: 10.7326/0003-4819-153-10-201011160-02003. Ann Intern Med. 2010. PMID: 21079210 No abstract available.

8

Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States.

Plantinga L, Grubbs V, Sarkar U, Hsu CY, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M, Powe N; CDC CKD Surveillance Team. Plantinga L, et al. Among authors: hsu cy. Ann Fam Med. 2011 Sep-Oct;9(5):423-30. doi: 10.1370/afm.1302. Ann Fam Med. 2011. PMID: 21911761 Free PMC article.

9

Measured GFR does not outperform estimated GFR in predicting CKD-related complications.

Hsu CY, Propert K, Xie D, Hamm L, He J, Miller E, Ojo A, Shlipak M, Teal V, Townsend R, Weir M, Wilson J, Feldman H; CRIC Investigators. Hsu CY, et al. J Am Soc Nephrol. 2011 Oct;22(10):1931-7. doi: 10.1681/ASN.2010101077. Epub 2011 Sep 15. J Am Soc Nephrol. 2011. PMID: 21921144 Free PMC article. Clinical Trial.

10

Acute kidney injury: comment on "trends in the incidence of acute kidney injury in patients hospitalized with acute myocardial infarction".

Hsu RK, Hsu CY. Hsu RK, et al. Among authors: hsu cy. Arch Intern Med. 2012 Feb 13;172(3):253-4. doi: 10.1001/archinternmed.2011.1606. Arch Intern Med. 2012. PMID: 22332158 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results